289 related articles for article (PubMed ID: 16469323)
1. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement].
Sumino H; Murakami M
Rinsho Byori; 2013 Mar; 61(3):256-62. PubMed ID: 23785796
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
[TBL] [Abstract][Full Text] [Related]
4. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
[TBL] [Abstract][Full Text] [Related]
5. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
6. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
Hypertens Res; 2005 Jul; 28(7):579-84. PubMed ID: 16335886
[TBL] [Abstract][Full Text] [Related]
7. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women.
Sumino H; Ichikawa S; Ohyama Y; Takahashi T; Saito Y; Nakamura T; Kanda T; Kurabayashi M
Am J Cardiol; 2005 Jul; 96(1):148-53. PubMed ID: 15979455
[TBL] [Abstract][Full Text] [Related]
8. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
9. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
[TBL] [Abstract][Full Text] [Related]
10. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
[TBL] [Abstract][Full Text] [Related]
11. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
[TBL] [Abstract][Full Text] [Related]
12. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.
Shifren JL; Rifai N; Desindes S; McIlwain M; Doros G; Mazer NA
J Clin Endocrinol Metab; 2008 May; 93(5):1702-10. PubMed ID: 18303079
[TBL] [Abstract][Full Text] [Related]
14. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
Hu P; Greendale GA; Palla SL; Reboussin BA; Herrington DM; Barrett-Connor E; Reuben DB
Atherosclerosis; 2006 Apr; 185(2):347-52. PubMed ID: 16023653
[TBL] [Abstract][Full Text] [Related]
15. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
16. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
17. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
[TBL] [Abstract][Full Text] [Related]
18. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
19. Transdermal estrogen reduces vascular resistance and serum cholesterol in postmenopausal women.
West SG; Hinderliter AL; Wells EC; Girdler SS; Light KC
Am J Obstet Gynecol; 2001 Apr; 184(5):926-33. PubMed ID: 11303200
[TBL] [Abstract][Full Text] [Related]
20. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women.
Lindheim SR; Duffy DM; Kojima T; Vijod MA; Stanczyk FZ; Lobo RA
Fertil Steril; 1994 Dec; 62(6):1176-80. PubMed ID: 7957980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]